Crestone has received an award from the Cystic Fibrosis Foundation (CFF) to develop preclinical studies for an antibiotic to treat non-tuberculous mycobacteria (NTM) infections. NTMs are responsible for lung infections in 14% of people with cystic fibrosis (CF). The number of people affected by lung NTM infections is steadily increasing in the U.S., and patients with an existing […]
The post Crestone Awarded Funding by Cystic Fibrosis Foundation to Develop Antibiotic That Fights NTM Infections appeared first on Cystic Fibrosis News Today. |
.png)
No hay comentarios:
Publicar un comentario